600511 国药股份
已收盘 10-23 15:00:00
资讯
新帖
简况
图解国药股份三季报：第三季度单季净利润同比增长9.70%
证券之星 · 10-21 17:44
图解国药股份三季报：第三季度单季净利润同比增长9.70%
国药股份（600511）10月20日主力资金净卖出675.80万元
证券之星 · 10-21 08:36
国药股份（600511）10月20日主力资金净卖出675.80万元
国药股份(600511)9月30日股东户数4.84万户，较上期增加2.47%
证券之星 · 10-20 17:21
国药股份(600511)9月30日股东户数4.84万户，较上期增加2.47%
国药股份(600511.SH)发布前三季度业绩，归母净利润14.76亿元，同比下降1.07%
智通财经 · 10-20 16:42
国药股份(600511.SH)发布前三季度业绩，归母净利润14.76亿元，同比下降1.07%
国药股份（600511）10月14日主力资金净卖出1146.47万元
证券之星 · 10-15
国药股份（600511）10月14日主力资金净卖出1146.47万元
国药股份（600511）9月28日主力资金净卖出352.15万元
证券之星 · 09-29
国药股份（600511）9月28日主力资金净卖出352.15万元
股市必读：国药股份新发布《国药股份关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-28
股市必读：国药股份新发布《国药股份关于召开2026年半年度业绩说明会的公告》
股市必读：国药股份新发布《国药股份关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-24
股市必读：国药股份新发布《国药股份关于召开2026年半年度业绩说明会的公告》
国药股份（600511）披露续签金融服务协议公告，8月31日股价下跌0.3%
证券之星 · 08-31
国药股份（600511）披露续签金融服务协议公告，8月31日股价下跌0.3%
每周股票复盘：国药股份（600511）拟续签财务公司服务协议
证券之星 · 08-30
每周股票复盘：国药股份（600511）拟续签财务公司服务协议
每周股票复盘：国药股份（600511）Q2净利降17.16%
证券之星 · 08-23
每周股票复盘：国药股份（600511）Q2净利降17.16%
国药股份2026年中报增收不增利：药品流通差价进一步压缩，子公司大幅亏损
蓝鲸财经 · 08-20
国药股份2026年中报增收不增利：药品流通差价进一步压缩，子公司大幅亏损
国药股份2026年半年报：净利润下滑 7%，供应链创新板块拖累盈利
蓝鲸财经 · 08-20
国药股份2026年半年报：净利润下滑 7%，供应链创新板块拖累盈利
股市必读：国药股份中报 - 第二季度单季净利润同比下降17.16%
证券之星 · 08-20
股市必读：国药股份中报 - 第二季度单季净利润同比下降17.16%
国药股份（600511）披露关于续签金融服务协议暨关联交易的议案，8月19日股价上涨0.44%
证券之星 · 08-19
国药股份（600511）披露关于续签金融服务协议暨关联交易的议案，8月19日股价上涨0.44%
国药控股(01099)与国药集团、国药股份拟4.06亿元出售国瑞药业合计51%股权
智通财经网 · 08-19
国药控股(01099)与国药集团、国药股份拟4.06亿元出售国瑞药业合计51%股权
国药股份(600511.SH)发布半年度业绩，归母净利润8.8亿元，同比下降7.25%
智通财经 · 08-19
国药股份(600511.SH)发布半年度业绩，归母净利润8.8亿元，同比下降7.25%
国药股份(600511)6月30日股东户数4.72万户，较上期减少1.14%
证券之星 · 08-19
国药股份(600511)6月30日股东户数4.72万户，较上期减少1.14%
国药控股与默沙东举行战略合作业务沟通会
智通财经 · 07-09
国药控股与默沙东举行战略合作业务沟通会
每周股票复盘：国药股份（600511）拟用8.54亿闲资补流
证券之星 · 07-05
每周股票复盘：国药股份（600511）拟用8.54亿闲资补流
公司概况
公司名称：
国药集团药业股份有限公司
所属行业：
批发业
上市日期：
2002-11-27
主营业务：
国药集团药业股份有限公司的主营业务是北京区域医疗机构直销；全国综合医药分销；麻精药品销售；供应链增值创新业务（供应链一体化服务、药械SPD、进口保税服务、口腔业务等）。公司的主要产品是药品、药品物流业务。
发行价格：
5.00
{"stockData":{"symbol":"600511","market":"SH","secType":"STK","nameCN":"国药股份","latestPrice":27.34,"timestamp":1792738800000,"preClose":27.34,"halted":0,"volume":7270600,"delay":0,"changeRate":0,"floatShares":553000000,"shares":755000000,"eps":2.625,"marketStatus":"已收盘","change":0,"latestTime":"10-23 15:00:00","open":27.27,"high":27.77,"low":27.17,"amount":200000000,"amplitude":0.0219,"askPrice":27.34,"askSize":13,"bidPrice":27.32,"bidSize":518,"shortable":0,"etf":0,"ttmEps":2.625,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":5,"adr":0,"adjPreClose":27.34,"symbolType":"stock","openAndCloseTimeList":[[1792719000000,1792726200000],[1792731600000,1792738800000]],"highLimit":30.07,"lowLimit":24.61,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":754502998,"isCdr":false,"pbRate":1.06,"roa":"--","peRate":10.415238,"roe":"7.79%","epsLYR":2.6462,"committee":0.600998,"marketValue":20628000000,"turnoverRate":0.0131,"status":2,"floatMarketCap":15128000000},"requestUrl":"/m/hq/s/600511/wiki","defaultTab":"wiki","newsList":[{"id":"2677462273","title":"图解国药股份三季报：第三季度单季净利润同比增长9.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677462273","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677462273?lang=zh_cn&edition=full","pubTime":"2026-10-21 17:44","pubTimestamp":1792575881,"startTime":"0","endTime":"0","summary":"证券之星消息，国药股份2026年三季报显示，前三季度公司主营收入406.06亿元，同比上升3.11%；归母净利润14.76亿元，同比下降1.07%；扣非净利润14.75亿元，同比上升0.36%；其中2026年第三季度，公司单季度主营收入138.78亿元，同比上升0.95%；单季度归母净利润5.96亿元，同比上升9.7%；单季度扣非净利润5.96亿元，同比上升10.59%；负债率42.56%，投资收益4.24亿元，财务费用-1547.63万元，毛利率6.32%。财报数据概要请见下图:本文数据来源于国药股份2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100030563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677648570","title":"国药股份（600511）10月20日主力资金净卖出675.80万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677648570","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677648570?lang=zh_cn&edition=full","pubTime":"2026-10-21 08:36","pubTimestamp":1792542973,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月20日收盘，国药股份报收于26.91元，下跌1.46%，换手率0.89%，成交量4.9万手，成交额1.32亿元。近5日资金流向一览见下表：国药股份融资融券信息显示，融资方面，当日融资买入1690.63万元，融资偿还1581.39万元，融资净买入109.24万元。国药股份主营业务：医药流通。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100007383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0250","BK0097","BK0012","600511","BK0082","BK0185","BK0028","BK0010","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676669619","title":"国药股份(600511)9月30日股东户数4.84万户，较上期增加2.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676669619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676669619?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:21","pubTimestamp":1792488094,"startTime":"0","endTime":"0","summary":"证券之星消息，近日国药股份披露，截至2026年9月30日公司股东户数为4.84万户，较6月30日增加1165.0户，增幅为2.47%。在医药商业行业个股中，国药股份股东户数高于行业平均水平，截至9月30日，医药商业行业平均股东户数为4.31万户。从股价来看，2026年6月30日至2026年9月30日，国药股份区间涨幅为0.23%，在此期间股东户数增加1165.0户，增幅为2.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000026086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","BK0012","BK0010","BK0250","BK0185","BK0082","600511","BK0028","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665474","title":"国药股份(600511.SH)发布前三季度业绩，归母净利润14.76亿元，同比下降1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665474","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665474?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:42","pubTimestamp":1792485738,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药股份(600511.SH)披露2026年第三季度报告，前三季度公司实现营业收入406.06亿元，同比增长3.11%;归母净利润14.76亿元，同比下降1.07%;扣非净利润14.75亿元，同比增长0.36%;基本每股收益1.9566元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509410.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675755263","title":"国药股份（600511）10月14日主力资金净卖出1146.47万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675755263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675755263?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:15","pubTimestamp":1792023326,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，国药股份报收于27.39元，上涨2.93%，换手率1.36%，成交量7.54万手，成交额2.04亿元。10月14日的资金流向数据方面，主力资金净流出1146.47万元，占总成交额5.61%，游资资金净流出631.16万元，占总成交额3.09%，散户资金净流入1777.63万元，占总成交额8.69%。近5日资金流向一览见下表：国药股份融资融券信息显示，融资方面，当日融资买入1587.13万元，融资偿还2120.54万元，融资净偿还533.41万元。国药股份主营业务：医药流通。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500006807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0010","BK0028","600511","BK0188","BK0250","BK0082","BK0175","BK0185","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671266262","title":"国药股份（600511）9月28日主力资金净卖出352.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671266262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671266262?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:27","pubTimestamp":1790641632,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，国药股份报收于25.85元，上涨0.47%，换手率0.52%，成交量2.9万手，成交额7480.44万元。9月28日的资金流向数据方面，主力资金净流出352.15万元，占总成交额4.71%，游资资金净流入256.7万元，占总成交额3.43%，散户资金净流入95.45万元，占总成交额1.28%。近5日资金流向一览见下表：国药股份融资融券信息显示，融资方面，当日融资买入468.05万元，融资偿还844.72万元，融资净偿还376.66万元。国药股份主营业务：医药流通。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900007191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","600511","BK0250","BK0175","BK0185","BK0082","BK0097","BK0028","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670018534","title":"股市必读：国药股份新发布《国药股份关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670018534","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670018534?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:48","pubTimestamp":1790534894,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，国药股份报收于25.73元，下跌1.46%，换手率0.69%，成交量3.81万手，成交额9853.62万元。当日关注点交易信息汇总：9月24日主力资金净流出295.66万元，占总成交额3.0%。公司公告汇总：国药股份将于2026年10月13日15:00-16:00召开2026年半年度业绩说明会。投资者可于2026年9月24日至10月12日16:00前通过上证路演中心网站或公司邮箱提交问题。说明会结束后可通过该平台查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0175","BK0012","BK0185","BK0010","BK0250","BK0082","600511","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669438440","title":"股市必读：国药股份新发布《国药股份关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669438440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669438440?lang=zh_cn&edition=full","pubTime":"2026-09-24 01:37","pubTimestamp":1790185030,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，国药股份报收于26.11元，下跌0.04%，换手率0.41%，成交量2.28万手，成交额5953.53万元。当日关注点交易信息汇总：9月23日主力资金净流入796.65万元，占总成交额13.38%。公司公告汇总：国药股份将于2026年10月13日15:00-16:00召开2026年半年度业绩说明会，通过上证路演中心进行网络互动。投资者可于2026年9月24日至10月12日16:00前通过上证路演中心网站或公司邮箱提交问题。说明会结束后可通过该平台查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0175","BK0097","BK0028","600511","BK0012","BK0185","BK0082","BK0188","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663907753","title":"国药股份（600511）披露续签金融服务协议公告，8月31日股价下跌0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663907753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663907753?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:01","pubTimestamp":1788174074,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，国药股份报收于26.69元，较前一交易日下跌0.3%，最新总市值为201.38亿元。近日，国药集团药业股份有限公司披露《2026年第三次临时股东会会议资料》，拟与国药集团财务有限公司续签《金融服务协议》。根据公告，协议有效期为三年，国药集团财务有限公司将为公司提供存款、贷款、结算等金融服务，并提供最高不超过20亿元的综合授信额度；公司及所属企业在国药财务的日均存款余额最高不超过12亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100029919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0010","BK0097","BK0012","600511","BK0175","BK0028","BK0185","BK0082","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663045908","title":"每周股票复盘：国药股份（600511）拟续签财务公司服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2663045908","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663045908?lang=zh_cn&edition=full","pubTime":"2026-08-30 10:06","pubTimestamp":1788055570,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，国药股份报收于26.77元，较上周的26.4元上涨1.4%。本周，国药股份8月26日盘中最高价报27.07元。本周关注点公司公告汇总：国药股份拟续签国药财务《金融服务协议》，获最高20亿元授信。公司公告汇总国药集团药业股份有限公司拟与国药集团财务有限公司续签《金融服务协议》，由国药财务提供存款、贷款、结算等金融服务，协议有效期三年。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0185","BK0012","BK0097","BK0188","BK0250","BK0028","600511","BK0010","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661214862","title":"每周股票复盘：国药股份（600511）Q2净利降17.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661214862","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661214862?lang=zh_cn&edition=full","pubTime":"2026-08-23 03:09","pubTimestamp":1787425749,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，国药股份报收于26.4元，较上周的27.22元下跌3.01%。本周关注点来自业绩披露要点：2026年第二季度归母净利润4.06亿元，同比下降17.16%。第二季度单季主营收入131.73亿元，同比增1.95%；单季归母净利润4.06亿元，同比下降17.16%；扣非净利润4.15亿元，同比下降14.54%。截至2026年6月30日，资产总额484.70亿元，净资产41.78亿元，资产负债率91.38%，资本充足率16.16%，流动性比例58.03%，监管指标均符合要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0028","BK0097","BK0010","BK0188","BK0175","BK0082","600511","BK0012","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660093734","title":"国药股份2026年中报增收不增利：药品流通差价进一步压缩，子公司大幅亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2660093734","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660093734?lang=zh_cn&edition=full","pubTime":"2026-08-20 14:46","pubTimestamp":1787208402,"startTime":"0","endTime":"0","summary":"受药品集采政策持续深化、市场竞争加剧等因素影响，国瑞药业2025年经营出现阶段性亏损。而受上述大额资产减值损失的影响，国瑞药业2026年上半年净利润亏损更是达到1.23亿元，标志着其经营状况的急剧恶化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787208248583895087","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0097","BK0175","BK0012","BK0185","BK0010","BK0250","BK0082","600511","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660470165","title":"国药股份2026年半年报：净利润下滑 7%，供应链创新板块拖累盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2660470165","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660470165?lang=zh_cn&edition=full","pubTime":"2026-08-20 11:27","pubTimestamp":1787196430,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月20日讯，8月19日，国药控股 旗下核心A股子公司国药股份披露2026年半年度报告。报告期内，国药股份实现营业收入267.28亿元，同比增长4.27%；归属于上市公司股东的净利润8.80亿元，同比下降7.25%；扣除非经常性损益后的净利润为8.80亿元，同比下降5.55%。截至2026年6月30日，公司资产总额达360.40亿元，负债总额为154.72亿元，基本每股收益为1.17元。然而，供应链创新增值培育板块尚处于投入期，新特药房等部分子公司出现亏损，拖累了整体盈利水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787191775813212495","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["600511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660420814","title":"股市必读：国药股份中报 - 第二季度单季净利润同比下降17.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660420814","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660420814?lang=zh_cn&edition=full","pubTime":"2026-08-20 02:18","pubTimestamp":1787163492,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘，国药股份报收于27.15元，上涨0.44%，换手率0.83%，成交量4.6万手，成交额1.25亿元。业绩披露要点：2026年中报显示归母净利润8.8亿元，同比下降7.25%；第二季度单季度归母净利润4.06亿元，同比下降17.16%。其中第二季度单季度主营收入131.73亿元，同比上升1.95%；单季度归母净利润4.06亿元，同比下降17.16%；单季度扣非净利润4.15亿元，同比下降14.54%；负债率42.93%，投资收益2.87亿元，财务费用-854.96万元，毛利率5.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000002186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429255","title":"国药股份（600511）披露关于续签金融服务协议暨关联交易的议案，8月19日股价上涨0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429255","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660429255?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:28","pubTimestamp":1787149697,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘，国药股份报收于27.15元，较前一交易日上涨0.44%，最新总市值为204.85亿元。该股当日开盘27.04元，最高27.38元，最低26.98元，成交额达1.25亿元，换手率为0.83%。会议将审议《关于与国药集团财务有限公司续签〈金融服务协议〉暨关联交易的议案》，关联股东国药控股股份有限公司需回避表决，中小投资者将单独计票。登记时间为2026年8月31日至9月1日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900043365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0175","600511","BK0010","BK0097","BK0028","BK0185","BK0250","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660426014","title":"国药控股(01099)与国药集团、国药股份拟4.06亿元出售国瑞药业合计51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426014","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660426014?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:05","pubTimestamp":1787148331,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药控股 发布公告，于2026年8月19日，本公司与国药集团、国药股份共同与国药现代订立股权转让协议，据此，本公司同意向国药现代出售本公司持有的目标公司国药集团国瑞药业有限公司30.13%股权，代价为人民币2.4亿元;国药股份同意向国药现代出售其持有的目标公司12.06%股权，代价为人民币9609.3万元;及国药集团同意向国药现代出售其持有的目标公司8.81%股权，代价为人民币7019.73万元。上述合计51%股权的转让代价合计为人民币4.06亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1115378108.SGD","BK0175","01099","BK0188","BK1515","BK0097","BK0185","BK1197","BK0012","LU0640798160.USD","BK0010","BK0028","BK0250","600511","BK0082","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660444604","title":"国药股份(600511.SH)发布半年度业绩，归母净利润8.8亿元，同比下降7.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660444604","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660444604?lang=zh_cn&edition=full","pubTime":"2026-08-19 18:14","pubTimestamp":1787134488,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药股份(600511.SH)披露2026年半年度报告，报告期公司实现营业收入267.28亿元，同比增长4.27%;归属于上市公司股东的净利润8.8亿元，同比下降7.25%;扣非净利润8.8亿元，同比下降5.55%;基本每股收益1.1660元。报告期内，公司重点医疗机构客户销售保持稳定，基层市场受集采降价等因素影响，同比有所下降。面对挑战，公司持续深化与重点医疗机构的战略合作，巩固集采药品、国谈创新药及生物制剂的院内配送保障，加快推进SPD院内供应链服务项目落地，以专业服务能力驱动直销板块业务规模保持稳定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482036.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"国药股份(600511.SH)发布半年度业绩，归母净利润8.8亿元，同比下降7.25%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660441705","title":"国药股份(600511)6月30日股东户数4.72万户，较上期减少1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660441705","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660441705?lang=zh_cn&edition=full","pubTime":"2026-08-19 18:01","pubTimestamp":1787133669,"startTime":"0","endTime":"0","summary":"证券之星消息，近日国药股份披露，截至2026年6月30日公司股东户数为4.72万户，较3月31日减少543.0户，减幅为1.14%。在医药商业行业个股中，国药股份股东户数高于行业平均水平，截至6月30日，医药商业行业平均股东户数为4.69万户。从股价来看，2026年3月31日至2026年6月30日，国药股份区间跌幅为8.51%，在此期间股东户数减少543.0户，减幅为1.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900031412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0097","BK0250","BK0012","BK0188","BK0185","600511","BK0082","BK0028","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650402869","title":"国药控股与默沙东举行战略合作业务沟通会","url":"https://stock-news.laohu8.com/highlight/detail?id=2650402869","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650402869?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:25","pubTimestamp":1783589154,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0203345920.USD","LU1093756168.USD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","IXJ","HRTS","LU1929549753.HKD","LU0265550359.USD","LU0122379950.USD","IE00BLSP4239.USD","LU2491049909.HKD","IE000M9KFDE8.USD","BK4516","LU2360032135.SGD","LU0211331839.USD","LU0130102774.USD","LU1066051498.USD","LU1066051225.USD","LU1974910355.USD","BK0028","LU1291159041.SGD","LU0965508806.USD","LU1934455194.USD","LU1116320901.HKD","BK0185","FHLC","IE00BSNM7G36.USD","LU0265550946.USD","LU0208291251.USD","PPH","LU2125154935.USD","LU1989771016.USD","LU1116320737.USD","BMED","LU1201861249.SGD","BK0097","LU1430594728.SGD","LU0289739699.SGD","LU2324357040.USD","BK4559","IE0009355771.USD","LU1162221912.USD","SG9999002224.SGD","LU0320765646.SGD","IE0002141913.USD","LU2112291526.USD","MRK","XLV","LU2089984988.USD","LU2491050071.SGD","LU2361044865.SGD","RXL","LU0006306889.USD","BK4007","IE00BBT3K403.USD","LU0070302665.USD","SGXZ57979304.SGD","LU1941712348.USD","SG9999002232.USD","600511","SG9999015341.SGD","BK4585","LU0965509101.SGD","LU1917777945.USD","LU1585245621.USD","GDOC","IE00BN8TJ469.HKD","LU0868494708.USD","IYH","SG9999001176.SGD","BK4588","IE00B2B36J28.USD","LU1035773651.USD","LU0861579265.USD","BK0082","BK0188","LU1983299246.USD","LU0868494617.USD","LU1066051811.HKD","LU0980610538.SGD","SG9999014575.USD","IE00BLSP4452.SGD","SG9999013999.USD","LU0985320562.USD","FTXH","LU1571399168.USD","LU2468319806.SGD","SG9999014542.SGD","LU0106261372.USD","BK4550","LU1699723380.USD","LU2361045086.USD","LU2461242641.AUD","LU1923622614.USD","LU1941712264.USD","LU1989772840.SGD","LU0238689110.USD","LU1934455277.USD","LU0477156953.USD","LU1037948897.HKD","LU0320765489.SGD","LU0098860793.USD","BK0012","LU2125154778.USD","BK4533","SG9999014559.SGD","LU2125909247.SGD","SG9999001440.SGD","LU0965509283.SGD","LU0432979614.USD","SG9999014567.USD","LU1093756325.SGD","LU2357627491.SGD","IE00B4R5TH58.HKD","LU2433249047.HKD","LU1066053197.SGD","JDOC","LU0130517989.USD","BK4534","IE00BJJMRZ35.SGD","LU0648001328.SGD","LU2125909593.SGD","IE00BJT1NW94.SGD","LU2361044949.HKD","LU1061106388.HKD","LU0859254822.USD","LU1989772923.USD","IHE","LU0203347892.USD","LU1069347547.HKD","BK0010","LU1023059063.AUD","LU0234572021.USD","LU1934455863.HKD","LU2491050154.USD","PAWZ","LU0965509010.AUD","BK0175","LU2023250504.SGD","LU0058720904.USD","LU2023250843.SGD","BK0250","LU1037948541.HKD","LU2106854487.HKD","LU0266013472.USD","SG9999001176.USD","VHT","LU0942090050.USD","SG9999015358.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649694031","title":"每周股票复盘：国药股份（600511）拟用8.54亿闲资补流","url":"https://stock-news.laohu8.com/highlight/detail?id=2649694031","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649694031?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:00","pubTimestamp":1783191637,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，国药股份报收于26.94元，较上周的25.7元上涨4.82%。本周，国药股份7月3日盘中最高价报27.01元。本周关注点公司公告汇总：国药股份拟使用不超过8.54亿元闲置募集资金临时补充流动资金，期限不超过12个月。国药股份计划使用不超过8.54亿元的闲置募集资金临时补充流动资金，使用期限自董事会审议通过之日起不超过12个月，资金将用于主营业务相关的生产经营，不改变募集资金用途，不影响募投项目正常进行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0175","BK0188","BK0185","600511","BK0097","BK0028","BK0250","BK0010","BK0012"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792742497832,"stockEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":0.0467},{"period":"3month","weight":0.0092},{"period":"6month","weight":-0.0254},{"period":"1year","weight":-0.0583},{"period":"ytd","weight":-0.021}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0744},{"period":"3month","weight":-0.0409},{"period":"6month","weight":-0.1034},{"period":"1year","weight":-0.0653},{"period":"ytd","weight":-0.0783}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国药集团药业股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"48411人(较上一季度增加2.47%)","perCapita":"11430股","listingDate":"2002-11-27","address":"北京市东城区永定门西滨河路8号院7楼西塔6-9层","registeredCapital":"75450万元","survey":" 国药集团药业股份有限公司的主营业务是北京区域医疗机构直销；全国综合医药分销；麻精药品销售；供应链增值创新业务（供应链一体化服务、药械SPD、进口保税服务、口腔业务等）。公司的主要产品是药品、药品物流业务。","listedPrice":5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药股份(600511)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药股份(600511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药股份,600511,国药股份股票,国药股份股票老虎,国药股份股票老虎国际,国药股份行情,国药股份股票行情,国药股份股价,国药股份股市,国药股份股票价格,国药股份股票交易,国药股份股票购买,国药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药股份(600511)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药股份(600511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}